Supplementary Material for: REal life study of LEnVAtiNib therapy for HepAtocellular carcinoma: RELEVANT study
Andrea Casadei‐Gardini, M. Rimini, Masatoshi Kudo, S. Shimose, Toshifumi Tada, Goki Suda, Goh M.J., André Jefremow, Mario Scartozzi, Giuseppe Cabibbo, Claudia Campani, Emiliano Tamburini, Francesco Tovoli, Kazuomi Ueshima, Tomoko Aoki, Hiroki Iwamoto, Takuji Torimura, Takashi Kumada, Atsushi Hiraoka, Masanori Atsukawa, Ei Itobayashi, Hideki Toyoda, Naoya Sakamoto, Sho T., Wonseok Kang, Jürgen Siebler, Neurath M.F., V. Burgio, Stefano CascinuSupplementary Material for: REal life study of LEnVAtiNib therapy for HepAtocellular carcinoma: RELEVANT study. , DOI: https://doi.org/10.6084/m9.figshare.20282028.
